Literature DB >> 26481310

DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.

Zhongbo Liu1, Oran D Kennedy1, Luis Cardoso1, Jelena Basta-Pljakic1, Nicola C Partridge1, Mitchell B Schaffler1, Clifford J Rosen1, Shoshana Yakar2.   

Abstract

Bone minerals are acquired during growth and are key determinants of adult skeletal health. During puberty, the serum levels of growth hormone (GH) and its downstream effector IGF-1 increase and play critical roles in bone acquisition. The goal of the current study was to determine how bone cells integrate signals from the GH/IGF-1 to enhance skeletal mineralization and strength during pubertal growth. Osteocytes, the most abundant bone cells, were shown to orchestrate bone modeling during growth. We used dentin matrix protein (Dmp)-1-mediated Ghr knockout (DMP-GHRKO) mice to address the role of the GH/IGF axis in osteocytes. We found that DMP-GHRKO did not affect linear growth but compromised overall bone accrual. DMP-GHRKO mice exhibited reduced serum inorganic phosphate and parathyroid hormone (PTH) levels and decreased bone formation indices and were associated with an impaired response to intermittent PTH treatment. Using an osteocyte-like cell line along with in vivo studies, we found that PTH sensitized the response of bone to GH by increasing Janus kinase-2 and IGF-1R protein levels. We concluded that endogenously secreted PTH and GHR signaling in bone are necessary to establish radial bone growth and optimize mineral acquisition during growth. © FASEB.

Entities:  

Keywords:  fibroblast growth factor-23; growth hormone receptor; microcomputed tomography; osteocyte; parathyroid hormone

Mesh:

Substances:

Year:  2015        PMID: 26481310      PMCID: PMC4714547          DOI: 10.1096/fj.15-275859

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  70 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Local IGF-I expression and bone formation.

Authors:  T L McCarthy; M Centrella
Journal:  Growth Horm IGF Res       Date:  2001-08       Impact factor: 2.372

3.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

Authors:  T Bellido; A A Ali; I Gubrij; L I Plotkin; Q Fu; C A O'Brien; S C Manolagas; R L Jilka
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

4.  PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

Authors:  Vardit Lavi-Moshayoff; Gilad Wasserman; Tomer Meir; Justin Silver; Tally Naveh-Many
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

5.  Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.

Authors:  Zhousheng Xiao; Mark Dallas; Ni Qiu; Daniel Nicolella; Li Cao; Mark Johnson; Lynda Bonewald; L Darryl Quarles
Journal:  FASEB J       Date:  2011-03-31       Impact factor: 5.191

6.  Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice.

Authors:  Yingjie Wu; Chengyu Liu; Hui Sun; Archana Vijayakumar; Pejman Raeisi Giglou; Ruifang Qiao; Joshua Oppenheimer; Shoshana Yakar; Derek LeRoith
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

Review 7.  Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.

Authors:  Roland Baron; Eric Hesse
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

8.  Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

Authors:  Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

9.  Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.

Authors:  Vaibhav Saini; Dean A Marengi; Kevin J Barry; Keertik S Fulzele; Erica Heiden; Xiaolong Liu; Christopher Dedic; Akira Maeda; Sutada Lotinun; Roland Baron; Paola Divieti Pajevic
Journal:  J Biol Chem       Date:  2013-06-02       Impact factor: 5.157

Review 10.  Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone.

Authors:  Matilda H C Sheng; K H William Lau; David J Baylink
Journal:  J Bone Metab       Date:  2014-02-28
View more
  13 in total

1.  Mitochondrial Function Is Compromised in Cortical Bone Osteocytes of Long-Lived Growth Hormone Receptor Null Mice.

Authors:  Zhongbo Liu; Maria E Solesio; Mitchell B Schaffler; Dorra Frikha-Benayed; Clifford J Rosen; Haim Werner; John J Kopchick; Evgeny V Pavlov; Andrey Y Abramov; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2018-09-14       Impact factor: 6.741

Review 2.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

Review 3.  Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Authors:  Manish Raisingani; Brar Preneet; Brenda Kohn; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2017-04-28       Impact factor: 2.372

Review 4.  Mice with gene alterations in the GH and IGF family.

Authors:  Yanrong Qian; Darlene E Berryman; Reetobrata Basu; Edward O List; Shigeru Okada; Jonathan A Young; Elizabeth A Jensen; Stephen R C Bell; Prateek Kulkarni; Silvana Duran-Ortiz; Patricia Mora-Criollo; Samuel C Mathes; Alison L Brittain; Mat Buchman; Emily Davis; Kevin R Funk; Jolie Bogart; Diego Ibarra; Isaac Mendez-Gibson; Julie Slyby; Joseph Terry; John J Kopchick
Journal:  Pituitary       Date:  2021-11-19       Impact factor: 4.107

Review 5.  Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.

Authors:  Zhongbo Liu; Subburaman Mohan; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2015-12-31       Impact factor: 2.372

6.  IGF-1 Mediates EphrinB1 Activation in Regulating Tertiary Dentin Formation.

Authors:  S Matsumura; A Quispe-Salcedo; C M Schiller; J S Shin; B M Locke; S Yakar; E Shimizu
Journal:  J Dent Res       Date:  2017-05-10       Impact factor: 6.116

Review 7.  Mouse models of growth hormone insensitivity.

Authors:  Jonathan Young; Stephen Bell; Yanrong Qian; Caroline Hyman; Darlene E Berryman
Journal:  Rev Endocr Metab Disord       Date:  2020-10-10       Impact factor: 6.514

Review 8.  Effects of GH/IGF axis on bone and cartilage.

Authors:  Manisha Dixit; Sher Bahadur Poudel; Shoshana Yakar
Journal:  Mol Cell Endocrinol       Date:  2020-10-14       Impact factor: 4.102

Review 9.  Tissue-Specific GHR Knockout Mice: An Updated Review.

Authors:  Akash Nagarajan; Hemant Srivastava; Joseph Jablonsky; Liou Y Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

10.  Programmed cell senescence in skeleton during late puberty.

Authors:  Changjun Li; Yu Chai; Lei Wang; Bo Gao; Hao Chen; Peisong Gao; Feng-Quan Zhou; Xianghang Luo; Janet L Crane; Bin Yu; Xu Cao; Mei Wan
Journal:  Nat Commun       Date:  2017-11-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.